ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Glycolysis inhibition was also shown by a significant TKI-induced reduction of glycoATP and decreased lactate levels in the supernatant of BCR::ABL1-positive CML cell lines (Fig. 1b,c).